Sara Wobker

17PUBLICATIONS
81CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosisLegal institutions (incl. courts and justice systems)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 08, 2026
Diagnostic challenges in pathologic staging of renal cell carcinoma following systemic immunotherapy.

|Mar 12, 2026
Intraductal histiocytes as a simulant of intraductal carcinoma of the prostate.

Sara E Wobker, Sean R Williamson, Alexander Kenigsberg

|Jun 13, 2025
Urothelial carcinoma-are we moving beyond "divergent differentiation" and "histologic subtype"?

Sara E Wobker, Steven Christopher Smith

|Mar 09, 2025
Interobserver reproducibility of a hybrid three-tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology study.

Michelle R Downes, Katherine Lajkosz, Ferran Algaba

|Jan 22, 2025
A pathologist's primer on implementing new standard-of-care molecular biomarker testing for precision prostate cancer management.

Steven C Smith, John W Melson, John M Quillin

|Nov 29, 2024
Unexpectedly high variability in determining tumour extent in prostatic biopsies: implications for active surveillance.

Marit Bernhardt, Leonie Weinhold, Felix Bremmer

Pageof 3

Frequent Collaborators

5 joint publications

Steven Christopher Smith

3 joint publications

Sean R Williamson

2 joint publications

Jeffrey S Damrauer

2 joint publications

Jon Oxley